R. Swingler

发表

The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.

R. Forbes, S. Colville, R. Swingler, 2004, Age and ageing.

Incidence of amyotrophic lateral sclerosis in Europe

E. Beghi, A. Chiò, O. Hardiman, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Prognostic factors in ALS: A critical review

E. Beghi, A. Chiò, O. Hardiman, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

The distribution of multiple sclerosis in the United Kingdom.

R. Swingler, D. Compston, 1986, Journal of neurology, neurosurgery, and psychiatry.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Annelot M. Dekker, Raymond D. Schellevis, P. Visscher, 2016, Nature Genetics.

The incidence of motor nueron disease in Scotland

R. Forbes, S. Colville, R. Swingler, 2007, Journal of Neurology.

Peripheral neuropathy simulating lymphoma.

D. Kean, R. Swingler, R. Cull, 1992, The British journal of radiology.

A Patient Suffering from Hypokalemic Periodic Paralysis Is Deficient in Skeletal Muscle ATP‐sensitive K+ channels

R. Buckley, R. Swingler, A. Jovanovic, 2008, Clinical and translational science.

Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of inter-observer agreement

R. Forbes, S. Colville, R. Swingler, 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

S. Chandran, T. Bak, J. Foley, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Rapid mutation detection by the Transgenomic wave analyser DHPLC identifies MYOC mutations in patients with ocular hypertension and/or open angle glaucoma

R. Swingler, C. MacEwen, G. Scott, 2002, The British journal of ophthalmology.

The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons

T. Révész, M. Goedert, M. Spillantini, 2013, Acta Neuropathologica.

Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations

M. Muqit, R. Swingler, E. Sammler, 2009, Movement disorders : official journal of the Movement Disorder Society.

CuZn-Superoxide Dismutase in D90A Heterozygotes from Recessive and Dominant ALS Pedigrees

P. Andersen, W. Robberecht, T. Siddique, 2002, Neurobiology of Disease.

50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis

Robert H. Brown, S. Purcell, J. Glass, 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis.

C. Hayward, R. Swingler, D. Brock, 1996, American journal of human genetics.

Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients.

R. Swingler, C. Jones, D. Brock, 1995, Journal of medical genetics.

Motor neuron disease and polio in Scotland.

C. Warlow, R. Swingler, H. Fraser, 1992, Journal of neurology, neurosurgery, and psychiatry.

Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register

R. Forbes, K. Kurian, S. Colville, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence.

P. Donnan, R. Forbes, R. Swingler, 2002, Neurology.

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease

S. Chandran, J. Chataway, M. Parmar, 2022, BMJ Open.

Amyotrophic lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot case-control study

E. Beghi, A. Chiò, O. Hardiman, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease

R. Forbes, G. Cran, S. Colville, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease

R. Forbes, S. Colville, F. T. I. Group, 2004, Journal of Neurology.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria

S. Chandran, R. Forbes, M. Hair, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Primary care access to computed tomography for chronic headache.

R. Swingler, G. Main, A. Cook, 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

HLA and multiple sclerosis in south east Wales.

R. Swingler, D. Compston, C. Darke, 1987, Journal of neurology, neurosurgery, and psychiatry.

Aspirin in type 2 diabetes : is there any evidence base ?

R. Swingler, R. Sanders, Iain Cruickshank, 2008 .

An epidemiologic study of multiple sclerosis in Northern Ireland.

R. Forbes, R. Swingler, 1999, Neurology.

Immunogenetics: genetic polymorphism and susceptibility to neurological disease

R. Swingler, D. Compston, 1988 .

The effect of anti-α4 integrin antibody on brain lesion activity in MS

Jacqueline Palace, A. Chaudhuri, D. Miller, 1999, Neurology.

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

I. Deary, S. Chandran, J. Prendergast, 2022, Journal of Neurology.

The brief Dimensional Apathy Scale: A short clinical assessment of apathy

J. Starr, S. Chandran, S. Abrahams, 2020, The Clinical neuropsychologist.

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

E. Beghi, G. Logroscino, A. Chiò, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis

R. Swingler, J. Parratt, J. O'Riordan, 2008, Multiple sclerosis.

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

S. Ennis, Robert H. Brown, P. Andersen, 2006, Nature Genetics.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

Denis C. Bauer, Annelot M. Dekker, Ashley R. Jones, 2017, Nature Communications.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

N. Pearce, A. Al-Chalabi, C. Shaw, 2014, The Lancet Neurology.

Urinary, faecal and sexual dysfunction in patients with multiple sclerosis

R. Swingler, D. Compston, N. Robertson, 1999, Journal of Neurology.

The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

P. Sandercock, B. Pentland, C. Warlow, 1992, Journal of neurology, neurosurgery, and psychiatry.

Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology.

R. Forbes, R. Swingler, 1999, American journal of epidemiology.

Multiple sclerosis and blood transfusion.

R. Swingler, 1993, Neuroepidemiology.

The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials

Adriano Chiò, Bryan J. Traynor, Giancarlo Logroscino, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions

S. Chandran, M. Porteous, S. Colville, 2016, Molecular and cellular probes.

Features of multiple sclerosis in older patients in South Wales.

A. D. White, R. Swingler, D. Compston, 1990, Gerontology.

Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others.

R. Swingler, C T Jones, R J Swingler, 1994, Human molecular genetics.

The prevalence of multiple sclerosis in south east Wales.

R. Swingler, D. Compston, 1988, Journal of neurology, neurosurgery, and psychiatry.

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis

D. Lulé, Colin Smith, S. Chandran, 2017, Acta Neuropathologica.

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

D. MacManus, A. Chaudhuri, D. Miller, 1999, Neurology.

Motor Neuron Diseasea Review

R. Swingler, J. Pritchard, 2000 .

ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation

K. Bushby, F. Muntoni, A. Schapira, 2013, Human mutation.

The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland

S. Chandran, M. Connor, S. Pal, 2020, Journal of Neurology.

Epidemiology of Presenile Alzheimer's Disease in Scotland (1974–88)

L. Whalley, G. Mcgonigal, R. Swingler, 1995, British Journal of Psychiatry.

Delayed presentation of invasive thymoma in myasthenia gravis: A case report

M. Farrugia, R. Swingler, E. Galizia, 2011, Neuromuscular Disorders.

Survival and cause of death in multiple sclerosis: a prospective population-based study

Y. Ben-Shlomo, R. Swingler, D. Compston, 2008, Journal of Neurology Neurosurgery & Psychiatry.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

A. Al-Chalabi, C. Shaw, O. Hardiman, 2018, Neurology.

Advanced glaucomatous visual loss and oral steroids

R. Swingler, V. Chadha, R. Sanders, 2008, BMJ : British Medical Journal.

The epidemiology of ALS and the role of population-based registries.

E. Beghi, G. Logroscino, A. Chiò, 2006, Biochimica et biophysica acta.

Genetic epidemiology of motor neuron disease-associated variants in the Scottish population

D. Goldstein, S. Chandran, T. Aitman, 2017, Neurobiology of Aging.

Corrigendum to “Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.” [Neurobiol. Aging 51 (2017) 178.e11–178.e20]

D. Goldstein, S. Chandran, T. Aitman, 2017, Neurobiology of Aging.

Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)

Ian R. White, S. Chandran, M. Parmar, 2023, Trials.

Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus.

R. Swingler, D. Davidson, I. Holt, 1993, Human molecular genetics.

Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis

C. Hayward, S. Colville, R. Swingler, 1999, Neurology.

Increasing prevalence and incidence of multiple sclerosis in South East Wales

G. Ingram, R. Swingler, D. Compston, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

M. Macleod, S. Chandran, J. Chataway, 2021, Brain communications.

Case report Delayed presentation of invasive thymoma in myasthenia gravis: A case report

M. Farrugia, R. Swingler, E. Galizia, 2011 .

Homozygosity for Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis.

C. Hayward, R. Swingler, R. Minns, 1998, Journal of medical genetics.

The morbidity of multiple sclerosis.

R. Swingler, D. Compston, Swingler Rj, 1992, The Quarterly journal of medicine.

A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland

S. Colville, R. Swingler, I. Grant, 2007, Journal of Neurology.

Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis

N. Waugh, R. Forbes, R. Swingler, 1999, BMJ.

Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus

Ashutosh Kumar Singh, S. Chandran, J. Chataway, 2023, BMJ Open.

A Systematic Approach to Identify Neuroprotective Interventions for Motor Neuron Disease

Ashutosh Kumar Singh, S. Chandran, J. Chataway, 2022, medRxiv.

The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register

J. Slattery, C. Warlow, R. Swingler, 1993, Journal of Neurology.

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

G. Ingram, R. Swingler, D. Compston, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

The incidence and mortality of multiple sclerosis in south east Wales.

R. Swingler, D. Compston, A. Hennessy, 1989, Journal of neurology, neurosurgery, and psychiatry.

Changing epidemiology of motor neurone disease in Scotland

S. Chandran, S. Colville, S. Pal, 2019, Journal of Neurology.

Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic

P. Donnan, R. Forbes, R. Swingler, 2005, Multiple sclerosis.

The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?

R. Forbes, R. Swingler, Sally V. Wilson, 1999, Journal of Neurology.

Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis

S. Chandran, S. Abrahams, Ratko Radakovic, 2017, Cortex.

Motor Neuron Disease is not clustered or associated with socioeconomic deprivation in Scotland.

S. Chandran, M. Connor, S. Pal, 2022, medRxiv.

Superoxide dismutase and amyotrophic lateral sclerosis

R. Swingler, D. Brock, C. Jones, 1995, The Lancet.

Demographic characteristics of multiple sclerosis in south east Wales.

R. Swingler, D. Compston, 1990, Neuroepidemiology.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure.

Adriano Chiò, Ammar Al-Chalabi, Ettore Beghi, 2007, Current medicinal chemistry.

Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland

S. Chandran, S. Abrahams, S. Colville, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

EFFECT OF REFERRAL BIAS ON ASSESSING SURVIVAL IN ALS

E. Beghi, A. Chiò, O. Hardiman, 2007, Neurology.

The cost of epilepsy in patients attending a specialist epilepsy service

R. Swingler, R. Roberts, D. Davidson, 1994, Seizure.

Not hysteria: ovarian teratoma-associated anti-N-methyl-d-aspartate receptor encephalitis

R. Roberts, R. Swingler, K. Abdelaziz, 2012, Scottish medical journal.

Re: "antibiotic use and risk of multiple sclerosis".

J. O'riordan, R. Swingler, J. Parratt, 2006, American journal of epidemiology.

Explorer Multidimensional apathy in ALS

S. Chandran, S. Abrahams, S. Colville, 2018 .

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

A. Al-Chalabi, C. Shaw, O. Hardiman, 2018, Neurology.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Effect of referral bias on assessing survival in ALS

J. Stevens, E. Beghi, G. Logroscino, 2007, Neurology.

Prognostic factors in ALS: A critical review

E. Beghi, A. Chiò, O. Hardiman, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Survival and cause of death in multiple sclerosis: a prospective population-based study

Y. Ben-Shlomo, R. Swingler, D. Compston, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials

E. Beghi, A. Chiò, O. Hardiman, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Amyotrophic lateral sclerosis and soccer: A different epidemiological approach strengthen the previous findings

E. Beghi, G. Logroscino, A. Chiò, 2008, Journal of the Neurological Sciences.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Annelot M. Dekker, Raymond D. Schellevis, Ashley R. Jones, 2016, Nature Genetics.

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

G. Ingram, R. Swingler, D. Compston, 2008, Journal of Neurology Neurosurgery & Psychiatry.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria

S. Chandran, R. Forbes, M. Hair, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis

R. Swingler, J. Parratt, J. O'Riordan, 2008, Multiple sclerosis.